SNT 9.09% 2.4¢ syntara limited

price, page-29

  1. 229 Posts.
    lightbulb Created with Sketch. 5

    Agree with the primacy of results: delivering successful RCT's and approvals etc. I think they have done a reasonable job so far in this regard, except perhaps for the bronchiectasis trial. I don't agree with Postman that the cash position and burn is a major factor, especially when bronchitol is close to market in both Aust/ Europe. The study results for CF were impressive and undeniable from a clinical viewpoint.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
2.4¢
Change
0.002(9.09%)
Mkt cap ! $28.65M
Open High Low Value Volume
2.2¢ 2.5¢ 2.2¢ $12.04K 509.9K

Buyers (Bids)

No. Vol. Price($)
1 82668 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 100000 1
View Market Depth
Last trade - 15.57pm 28/06/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.